Cancer Biomarkers Market

The cancer biomarkers market involves using biological molecules to detect, diagnose, and monitor cancer. Primary customers include healthcare providers and pharmaceutical companies engaged in drug discovery and personalized medicine. Growth is driven by the increasing global prevalence of cancer, advancements in genomic and proteomic technologies, and a rising demand for personalized therapies.